These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8993076)

  • 1. Pharmacokinetic and pharmacodynamic drug interactions with polypharmacotherapy of treatment-resistant affective and obsessive-compulsive disorders.
    Carson SW
    Psychopharmacol Bull; 1996; 32(4):555-68. PubMed ID: 8993076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The obsessive-compulsive disorder. Pharmacotherapeutic and neurobiological aspects and the relation to affective pathology].
    Fornaro P
    Minerva Psichiatr; 1988; 29(2):95-103. PubMed ID: 3057306
    [No Abstract]   [Full Text] [Related]  

  • 3. Antidepressant drugs in dermatology.
    Gupta MA; Gupta AK
    Skin Therapy Lett; 2001 May; 6(8):3-5. PubMed ID: 11438813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psychostimulants: a potential therapeutic alternative in mood and obsessive compulsive disorders (first part)].
    Samain V
    Rev Med Brux; 2003 Dec; 24(6):464-9. PubMed ID: 14748179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues in the monopharmacotherapy and polypharmacotherapy of obsessive-compulsive disorder.
    Laird LK
    Psychopharmacol Bull; 1996; 32(4):569-78. PubMed ID: 8993077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Psychostimulants: a therapeutic alternative in thymic and obsessive compulsive disorders (second part)].
    Samain V
    Rev Med Brux; 2004 Feb; 25(1):29-39. PubMed ID: 15053152
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
    Kamijima K; Aoki M
    Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antidepressive agents in the treatment of obsessive-compulsive disorder].
    Hansen ES; Bolwig TG
    Ugeskr Laeger; 1997 Jan; 159(2):183-4. PubMed ID: 9012092
    [No Abstract]   [Full Text] [Related]  

  • 9. Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: a meta-analysis of the randomized controlled trials.
    Skapinakis P; Papatheodorou T; Mavreas V
    Eur Neuropsychopharmacol; 2007 Jan; 17(2):79-93. PubMed ID: 16904298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug treatment of compulsive disorder].
    Rapoport JL
    Nervenarzt; 1991 May; 62(5):318-20. PubMed ID: 1865964
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antidepressive agents in non-depressive disorders].
    Peyré F
    Rev Prat; 1994 Nov; 44(17):2299-301. PubMed ID: 7984935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakthrough in psychiatric care. Pharmacological treatment of obsessive-compulsive disorders with implications for nursing care.
    Giger JN; Davidhizar R; Poole VL; Malone SB
    J Pract Nurs; 2000 Mar; 50(1):23-8; quiz 29-31. PubMed ID: 11951236
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ziprasidone as coadjuvant treatment in resistant obsessive-compulsive disorder treatment].
    Iglesias Garcia C; Santamarina Montila S; Alonso Villa MJ
    Actas Esp Psiquiatr; 2006; 34(4):277-9. PubMed ID: 16823689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newer antipsychotics: comparative review of drug interactions.
    Spina E; Scordo MG
    Expert Rev Neurother; 2001 Nov; 1(2):171-82. PubMed ID: 19811029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond depression. What do those "mood drugs" really do?
    Lemonick MD
    Time; 1999 May; 153(19):74. PubMed ID: 10387666
    [No Abstract]   [Full Text] [Related]  

  • 16. On the selection and use of atypical antipsychotics in the management of nonpsychotic mood and anxiety disorders.
    Blier P
    J Psychiatry Neurosci; 2005 Jul; 30(4):304. PubMed ID: 16049572
    [No Abstract]   [Full Text] [Related]  

  • 17. [Practice guidelines--therapy of anxiety and compulsive disorders. Recommendations for therapy of anxiety and compulsive disorders of the Drug Commission of the German Medical Society].
    Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):241-4. PubMed ID: 10802900
    [No Abstract]   [Full Text] [Related]  

  • 18. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S; Harvey BH
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities in the primary affective disorders compared to other tricyclic-responsive disorders.
    Siever LJ; Uhde TW; Insel TR; Kaye WH; Jimerson DC; Lake CR; Kafka M; Targum S; Murphy L
    Psychopharmacol Bull; 1983; 19(3):435-6. PubMed ID: 6635119
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment-resistant affective disorders.
    Bowskill RJ; Bridges PK
    Br J Hosp Med; 1997 Feb 19-Mar 4; 57(4):171-2. PubMed ID: 9166385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.